ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 109 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $327 | -25.3% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $438 | -99.9% | 30,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $565,000 | +82.3% | 30,000 | +114.3% | 0.00% | +100.0% |
| Q2 2022 | $310,000 | +18.3% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $262,000 | +0.8% | 14,000 | +10.2% | 0.00% | 0.0% |
| Q4 2021 | $260,000 | -7.1% | 12,700 | +2.4% | 0.00% | 0.0% |
| Q3 2021 | $280,000 | -12.5% | 12,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $320,000 | -4.2% | 12,400 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $334,000 | -6.7% | 12,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $358,000 | – | 12,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |